F. Aerts

766 total citations
25 papers, 627 citations indexed

About

F. Aerts is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, F. Aerts has authored 25 papers receiving a total of 627 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Cell Biology. Recurrent topics in F. Aerts's work include Microtubule and mitosis dynamics (5 papers), Antifungal resistance and susceptibility (3 papers) and Cancer Treatment and Pharmacology (3 papers). F. Aerts is often cited by papers focused on Microtubule and mitosis dynamics (5 papers), Antifungal resistance and susceptibility (3 papers) and Cancer Treatment and Pharmacology (3 papers). F. Aerts collaborates with scholars based in Belgium, Netherlands and United States. F. Aerts's co-authors include M. De Brabander, Μ. Borgers, G. Geuens, J. Van Cutsem, H. Van den Bossche, Rudy Willebrords, Johan De Mey, J. Richard McIntosh, Rony Nuydens and J. Van Wauwe and has published in prestigious journals such as Nature, JNCI Journal of the National Cancer Institute and Antimicrobial Agents and Chemotherapy.

In The Last Decade

F. Aerts

25 papers receiving 545 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. Aerts Belgium 14 233 186 87 85 80 25 627
P. Badenoch‐Jones United Kingdom 14 284 1.2× 119 0.6× 47 0.5× 97 1.1× 131 1.6× 36 741
Virgil R. Mumaw United States 15 242 1.0× 65 0.3× 83 1.0× 99 1.2× 144 1.8× 31 862
I Covelli Italy 18 378 1.6× 147 0.8× 91 1.0× 62 0.7× 52 0.7× 44 921
S. Yoshida Japan 17 487 2.1× 64 0.3× 48 0.6× 137 1.6× 58 0.7× 39 749
Mau-Sun Chang Taiwan 20 529 2.3× 140 0.8× 88 1.0× 128 1.5× 106 1.3× 41 864
P Saikumar United States 11 429 1.8× 70 0.4× 38 0.4× 56 0.7× 107 1.3× 14 633
William McDowell Germany 12 383 1.6× 121 0.7× 33 0.4× 53 0.6× 73 0.9× 25 764
Yuki Nagai Japan 13 556 2.4× 162 0.9× 112 1.3× 43 0.5× 179 2.2× 28 907
Carlos J. Pérez United States 16 431 1.8× 66 0.4× 56 0.6× 111 1.3× 95 1.2× 29 776
Björn Magnusson Sweden 13 394 1.7× 134 0.7× 85 1.0× 17 0.2× 90 1.1× 19 839

Countries citing papers authored by F. Aerts

Since Specialization
Citations

This map shows the geographic impact of F. Aerts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Aerts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Aerts more than expected).

Fields of papers citing papers by F. Aerts

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Aerts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Aerts. The network helps show where F. Aerts may publish in the future.

Co-authorship network of co-authors of F. Aerts

This figure shows the co-authorship network connecting the top 25 collaborators of F. Aerts. A scholar is included among the top collaborators of F. Aerts based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Aerts. F. Aerts is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aerts, F., et al.. (2014). Autolytic degradation of ocriplasmin: a complex mechanism unraveled by mutational analysis. Protein Engineering Design and Selection. 27(7). 215–223. 5 indexed citations
2.
Aerts, F., et al.. (2012). Mechanism of inactivation of ocriplasmin in porcine vitreous. Biophysical Chemistry. 165-166. 30–38. 13 indexed citations
3.
Wauwe, J. Van, F. Aerts, Marina Cools, et al.. (2000). Identification of R146225 as a Novel, Orally Active Inhibitor of Interleukin-5 Biosynthesis. Journal of Pharmacology and Experimental Therapeutics. 295(2). 655–661. 17 indexed citations
4.
Wauwe, J. Van, et al.. (1996). The inhibitory effect of pentamidine on the production of chemotactic cytokines by in vitro stimulated human blood cells. Inflammation Research. 45(7). 357–363. 12 indexed citations
5.
Wauwe, J. Van, F. Aerts, H. Walter, & Mark de Boer. (1995). Cytokine production by phytohemagglutinin-stimulated human blood cells: Effects of corticosteroids, T cell immunosuppressants and phosphodiesterase IV inhibitors. Inflammation Research. 44(9). 400–405. 37 indexed citations
6.
Cools, Marina, F. Aerts, & J. Van Wauwe. (1992). Lack of immunosuppression by ketoconazole and itraconazole. International Journal of Immunopharmacology. 14(6). 1011–1017. 5 indexed citations
7.
Vogels, O.J.M., Ryan DeCoster, F. Aerts, et al.. (1992). THE EFFECTS OF SHORT-TERM TREATMENT WITH LEVAMISOLE ON CYTOKINES IN VOLUNTEERS AND CANCER-PATIENTS. International Journal of Oncology. 1(3). 337–40. 1 indexed citations
8.
Brabander, M. De, G. Geuens, Rony Nuydens, et al.. (1986). Microtubule Dynamics during the Cell Cycle: The Effects of Taxol and Nocodazole on the Microtubule System of Pt K2 Cells at Different Stages of the Mitotic Cycle. International review of cytology. 101. 215–274. 124 indexed citations
9.
10.
Brabander, M. De, F. Aerts, Johan De Mey, et al.. (1985). Microtubule Dynamics and the Mitotic Cycle: A Model. PubMed. 36. 269–278. 1 indexed citations
11.
Hommes, O. R., F. Aerts, U. Bahr, & H.‐R. Schulten. (1983). Cyclophosphamide levels in serum and spinal fluid of multiple sclerosis patients treated with immunosuppression. Journal of the Neurological Sciences. 58(2). 297–303. 22 indexed citations
12.
Bahr, U., H.‐R. Schulten, O. R. Hommes, & F. Aerts. (1980). Determination of cyclophosphamide in urine, serum and cerebrospinal fluid of multiple sclerosis patients by field desorption mass spectrometry. Clinica Chimica Acta. 103(2). 183–192. 30 indexed citations
13.
Aerts, F., M. De Brabander, H. Van den Bossche, J. Van Cutsem, & Μ. Borgers. (1980). The Activity of Ketoconazole in Mixed Cultures of Fungi and Human Fibroblasts: Die Wirkung von Ketoconazol in Mischkulturen von Pilzen und menschlichen Fibroblasten. Mycoses. 23(2). 53–67. 38 indexed citations
14.
Brabander, M. De, F. Aerts, J. Van Cutsem, H. Van den Bossche, & Μ. Borgers. (1980). The activity of ketoconazole in mixed cultures of leukocytes and Candida albicans. Medical Mycology. 18(3). 197–210. 56 indexed citations
15.
Brabander, M. De, et al.. (1979). Protective effect of levamisole and its sulfhydryl metabolite OMPI against cell death induced by glutathione depletion. International Journal of Immunopharmacology. 1(2). 93–100. 24 indexed citations
16.
Brabander, M. De, et al.. (1978). Dl-2-oxo-3-(2-mercaptoethyl)-5-phenylimidazolidine. A sulfhydryl metabolite of levamisole that interacts with microtubules. Chemico-Biological Interactions. 23(1). 45–63. 22 indexed citations
17.
Brabander, M. De, G. Geuens, F. Thoné, et al.. (1977). The effects of R 17934 (NSC 238159), a new antimicrotubular substance, on the ultrastructure of neoplastic cells in vivo. European Journal of Cancer (1965). 13(6). 511–528. 15 indexed citations
18.
Brabander, M. De, et al.. (1977). Microtubules in mammalian cell shape and surface modulation: An alternative hypothesis. Cell Biology International Reports. 1(5). 453–461. 24 indexed citations
19.
Brabander, M. De, et al.. (1976). A New Culture Model Facilitating Rapid Quantitative Testing of Mitotic Spindle Inhibition in Mammalian Cells2. JNCI Journal of the National Cancer Institute. 56(2). 357–363. 68 indexed citations
20.
Brabander, M. De, F. Aerts, & Μ. Borgers. (1974). The influence of a glucocorticoid on the lodgement and development in the lungs of intravenously injected tumour cells. European Journal of Cancer (1965). 10(11). 751–755. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by P. Badenoch‐Jones Breakdown of academic impact, for papers by Virgil R. Mumaw Breakdown of academic impact, for papers by I Covelli Breakdown of academic impact, for papers by S. Yoshida Breakdown of academic impact, for papers by Mau-Sun Chang Breakdown of academic impact, for papers by P Saikumar Breakdown of academic impact, for papers by William McDowell Breakdown of academic impact, for papers by Yuki Nagai Breakdown of academic impact, for papers by Carlos J. Pérez Breakdown of academic impact, for papers by Björn Magnusson
Rankless by CCL
2026